alexa Abstract | Ischemia modified albumin in patients of cardiac and non-cardiac chest pain

Biomedical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Existing biochemical markers are not suitable for assessing early myocardial ischemia particularly in first 2-6 hours of ischemia i.e. before setting in of irreparable myocardial damage. Recently ischemia modified albumin (IMA) has emerged as the earliest cardiac marker. Therefore, this study was planned to estimate IMA levels in patients of acute chest pain with or without cardiac cause. One hundred patients of acute chest pain (50 patients with cardiac cause and 50 patients with non-cardiac cause) were selected for the study and compared with 50 age and sex matched healthy controls. IMA, creatine kinase- MB (CK-MB), Troponin I, routine biochemical investigations, hemoglobin and total leucocyte count were estimated in these patients. The results were analysed statistically. IMA levels were found to be significantly elevated in patients of chest pain with myocardial ischemia as compared to the other two groups. A significant positive correlation was found between IMA levels & CKMB levels (r = +0.713, p value<0.001) and IMA levels & troponin I levels (r = +0.823, p value<0.001) but a poor correlation was observed between IMA levels and SGOT levels (r = - .012, p value>0.05). Thus we conclude that IMA assay is a sensitive but not very specific marker for early detection of myocardial ischemia. IMA can be combined with other biochemical markers like CK-MB and Troponin I to increase the specificity. Other non myocardial ischemic conditions should be kept in mind while interpreting IMA values.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Kavita Aggarwal Shashi Seth Kiran Dahiya HK Aggarwal Mahesh Kumar Aggarwal


Ischemia modified albumin, CK-MB, Troponin I, Myocardial ischemia, Non-cardiac chest pain

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us